These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16176438)

  • 1. Reductions in cholesterol and synaptic markers in association cortex in mood disorders.
    Beasley CL; Honer WG; Bergmann K; Falkai P; Lütjohann D; Bayer TA
    Bipolar Disord; 2005 Oct; 7(5):449-55. PubMed ID: 16176438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
    Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
    Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
    J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders.
    Kurt E; Guler O; Serteser M; Cansel N; Ozbulut O; Altinbaş K; Alataş G; Savaş H; Gecici O
    Neurosci Lett; 2007 Oct; 426(1):49-53. PubMed ID: 17884293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
    Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
    Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.
    Bielau H; Steiner J; Mawrin C; Trübner K; Brisch R; Meyer-Lotz G; Brodhun M; Dobrowolny H; Baumann B; Gos T; Bernstein HG; Bogerts B
    Ann N Y Acad Sci; 2007 Jan; 1096():157-69. PubMed ID: 17405927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
    Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia.
    Jow GM; Yang TT; Chen CL
    J Affect Disord; 2006 Jan; 90(1):21-7. PubMed ID: 16324751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.
    Grassi-Oliveira R; Stein LM; Lopes RP; Teixeira AL; Bauer ME
    Biol Psychiatry; 2008 Aug; 64(4):281-5. PubMed ID: 18406398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
    Torres KC; Souza BR; Miranda DM; Nicolato R; Neves FS; Barros AG; Dutra WO; Gollob KJ; Correa H; Romano-Silva MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):214-9. PubMed ID: 19059449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of glutamate in brains from patients with mood disorders.
    Hashimoto K; Sawa A; Iyo M
    Biol Psychiatry; 2007 Dec; 62(11):1310-6. PubMed ID: 17574216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
    Uezato A; Meador-Woodruff JH; McCullumsmith RE
    Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of age at onset and affective temperaments in a Norwegian sample of patients with mood disorders.
    Oedegaard KJ; Syrstad VE; Morken G; Akiskal HS; Fasmer OB
    J Affect Disord; 2009 Nov; 118(1-3):229-33. PubMed ID: 19243836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the medical lethality of suicide attempts in bipolar and major depressive disorders.
    Zalsman G; Braun M; Arendt M; Grunebaum MF; Sher L; Burke AK; Brent DA; Chaudhury SR; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):558-65. PubMed ID: 17042829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins.
    Eastwood SL; Harrison PJ
    Brain Res Bull; 2001 Jul; 55(5):569-78. PubMed ID: 11576753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.
    Su TP; Zhang L; Chung MY; Chen YS; Bi YM; Chou YH; Barker JL; Barrett JE; Maric D; Li XX; Li H; Webster MJ; Benedek D; Carlton JR; Ursano R
    J Psychiatr Res; 2009 Sep; 43(13):1078-85. PubMed ID: 19380152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice.
    Eastwood SL; Lyon L; George L; Andrieux A; Job D; Harrison PJ
    J Psychopharmacol; 2007 Aug; 21(6):635-44. PubMed ID: 17050659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.
    Zimmermann P; Brückl T; Nocon A; Pfister H; Lieb R; Wittchen HU; Holsboer F; Angst J
    Arch Gen Psychiatry; 2009 Dec; 66(12):1341-52. PubMed ID: 19996039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder.
    Kahl KG; Bens S; Ziegler K; Rudolf S; Dibbelt L; Kordon A; Schweiger U
    Biol Psychiatry; 2006 Apr; 59(7):667-71. PubMed ID: 16199015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.